HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

CSTONE PHARMA-B

8.700

-0.050-0.57%

Volume:26.01M

Turnover:229.59M

Market Cap:12.84B

PE:-24.38

High:9.090

Open:8.830

Low:8.600

Close:8.750

52wk High:13.150

52wk Low:2.030

Shares:1.48B

HK Float Shares:1.48B

Volume Ratio:0.87

T/O Rate:1.76%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-0.357

ROE:-89.13%

ROA:-18.89%

PB:18.37

PE(LYR):-24.38

PS:42.02

Loading ...

Overview Company News Filings

CStone Pharmaceuticals to present preclinical data for three pipeline assets at AACR Annual Meeting

CStone Pharmaceuticals (SEHK:2616) Valuation Check After New UK Approval For Sugemalimab In Stage III Lung Cancer

Simply Wall St.

CSTONE PHARMA-B Shares Surge Over 9% Following FTSE China Inclusion and Progress in Triple Antibody Trial

CSTONE PHARMA-B Surges Over 12% on Promising Prospects for Major Business Development Deal for its Proprietary Tri-Specific Antibody

CStone Pharmaceuticals (SEHK:2616) Valuation After New Sugemalimab Indication And US Phase II Trial Clearance

Simply Wall St.

CSTONE PHARMA-B Shares Surge Over 8% in Late Trading Following UK Approval for New Lung Cancer Indication

CStone Pharmaceuticals-B Sees Further Gains Exceeding 6%, Surpassing 25% Monthly Increase

CStone Pharmaceuticals-B Shares Climb Over 5% Following UK Regulatory Approval for Sugemalimab's New Lung Cancer Indication

CStone (HKEX: 2616) Gains UK MHRA Approval for Sugemalimab in Stage III NSCLC

Bulletin Express

CStone Pharma-B's PD-L1 Antibody Sugemalimab Gains UK Approval for Advanced Lung Cancer

CStone Pharmaceuticals - Sugemalimab Receives UK Mhra Approval for Stage Iii Nsclc

THOMSON REUTERS

UK MHRA approves CStone’s sugemalimab for unresectable stage III NSCLC

CSTONE PHARMA-B Receives FDA Clearance for Phase II Trial of CS2009

CStone Pharmaceuticals (HKEX: 2616) Announces U.S. FDA IND Clearance for Phase II Trial of CS2009 Trispecific Antibody

Bulletin Express

CStone Pharmaceuticals' CS2009 Tri-Specific Antibody Phase II Trial Receives FDA Clearance

CStone Pharmaceuticals Receives FDA Clearance for Phase II Trial of CS2009

CStone Pharmaceuticals - FDA Clears Ind Application for Cs2009 Phase Ii Trial

THOMSON REUTERS

CStone Pharmaceuticals (2616) Updates Joint Company Secretary Qualification and Announces Personnel Changes

Bulletin Express

CStone Pharmaceuticals-B Receives Exchange Approval for Company Secretary Qualification

CStone Pharmaceuticals Appoints Weicong Ni as Sole Company Secretary

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/02616/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02616","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02616\",,,,,undefined,":{"symbol":"02616","market":"HK","secType":"STK","nameCN":"CSTONE PHARMA-B","latestPrice":8.7,"timestamp":1774944505007,"preClose":8.75,"halted":0,"volume":26010789,"delay":0,"changeRate":-0.005714285714285796,"floatShares":1476000000,"shares":1476000000,"eps":-0.35680496553021684,"marketStatus":"Closed","change":-0.05,"latestTime":"03-31 16:08:25","open":8.83,"high":9.09,"low":8.6,"amount":229592103,"amplitude":0.056,"askPrice":8.7,"askSize":390000,"bidPrice":8.69,"bidSize":9500,"shortable":3,"etf":0,"ttmEps":-0.3718229866495245,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1775007000000},"marketStatusCode":5,"adr":0,"listingDate":1551110400000,"exchange":"SEHK","adjPreClose":8.75,"openAndCloseTimeList":[[1774920600000,1774929600000],[1774933200000,1774944000000]],"volumeRatio":0.873846,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02616\",,,,,undefined,":{"symbol":"02616","floatShares":1476000000,"roa":"-18.89%","roe":"-89.13%","lyrEps":-0.356827,"volumeRatio":0.873846,"shares":1476000000,"dividePrice":0,"high":9.09,"amplitude":0.056,"preClose":8.75,"low":8.6,"week52Low":2.03,"pbRate":"18.37","psRate":"42.02","week52High":13.15,"institutionHeld":0,"latestPrice":8.7,"committee":-0.952441,"eps":-0.35682717269384834,"divideRate":0,"volume":26010789,"delay":0,"ttmEps":-0.37184612851890464,"open":8.83,"prevYearClose":5.27,"prevWeekClose":8.33,"prevMonthClose":6.68,"prevQuarterClose":5.27,"fiveDayClose":6.6,"twentyDayClose":6.26,"sixtyDayClose":5.27},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02616\",params:#limit:5,,,undefined,":[{"date":"2026-03-26","symbol":"02616","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774488600000,"name":null,"time":"","dateTimestamp":1774454400000,"actualEps":null},{"date":"2025-08-14","symbol":"02616","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1755135000000,"name":null,"time":"","dateTimestamp":1755100800000,"actualEps":null},{"date":"2025-03-27","symbol":"02616","type":"earning","reportTimeType":"pre","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1743039000000,"name":null,"time":"Pre-Market","dateTimestamp":1743004800000,"actualEps":null},{"date":"2024-08-23","symbol":"02616","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724376600000,"name":null,"time":"","dateTimestamp":1724342400000,"actualEps":null},{"date":"2024-03-27","symbol":"02616","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1711503000000,"name":null,"time":"","dateTimestamp":1711468800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02616\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02616\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.5,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5,"analysts":2,"updateTime":1761235200000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02616\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02616","date":"2026-03-30","current":-23.398231,"percent":0.127555,"low":-136.537801,"twenty":-20.271147,"median":-4.385799,"eighty":-2.920519,"high":-1.28563,"avg":-13.059091,"sd":18.184583,"marketCap":12883518585},"quantilePoints":[{"date":"2021-04-01","current":-5.504925,"twenty":-5.966211,"median":-5.498781,"eighty":-5.169027,"marketCap":11370986981},{"date":"2021-04-09","current":-5.253014,"twenty":-5.959824,"median":-5.476126,"eighty":-5.193767,"marketCap":10874588565},{"date":"2021-04-16","current":-4.972095,"twenty":-5.951554,"median":-5.429969,"eighty":-5.100806,"marketCap":10332013551},{"date":"2021-04-23","current":-5.364215,"twenty":-5.876914,"median":-5.418019,"eighty":-5.057644,"marketCap":11174736444},{"date":"2021-04-30","current":-8.767423,"twenty":-5.975594,"median":-5.425585,"eighty":-5.068634,"marketCap":12840594630},{"date":"2021-05-07","current":-8.052957,"twenty":-6.025332,"median":-5.452357,"eighty":-5.100806,"marketCap":11870621655},{"date":"2021-05-14","current":-8.07388,"twenty":-6.138262,"median":-5.498781,"eighty":-5.143896,"marketCap":11893716249},{"date":"2021-05-21","current":-9.544929,"twenty":-6.246034,"median":-5.508942,"eighty":-5.161637,"marketCap":14064608147},{"date":"2021-05-28","current":-9.870842,"twenty":-7.79114,"median":-5.523982,"eighty":-5.165476,"marketCap":14688162203},{"date":"2021-06-04","current":-9.908101,"twenty":-8.065511,"median":-5.542034,"eighty":-5.185521,"marketCap":14673709159},{"date":"2021-06-11","current":-11.188388,"twenty":-8.42064,"median":-5.601428,"eighty":-5.220093,"marketCap":16568581837},{"date":"2021-06-18","current":-13.356489,"twenty":-8.716461,"median":-5.643073,"eighty":-5.235781,"marketCap":19618864686},{"date":"2021-06-25","current":-13.538063,"twenty":-9.361643,"median":-5.692493,"eighty":-5.240484,"marketCap":19873054924},{"date":"2021-07-02","current":-12.785549,"twenty":-9.908101,"median":-5.824169,"eighty":-5.244249,"marketCap":18735613713},{"date":"2021-07-09","current":-11.771342,"twenty":-10.201154,"median":-5.955566,"eighty":-5.252928,"marketCap":17232138538},{"date":"2021-07-16","current":-14.078499,"twenty":-10.63624,"median":-5.99556,"eighty":-5.253014,"marketCap":20609175084},{"date":"2021-07-23","current":-12.799867,"twenty":-11.188388,"median":-6.024244,"eighty":-5.262245,"marketCap":18735613713},{"date":"2021-07-30","current":-11.308061,"twenty":-11.301942,"median":-6.036857,"eighty":-5.309674,"marketCap":16607618081},{"date":"2021-08-06","current":-10.675922,"twenty":-11.308061,"median":-6.140616,"eighty":-5.317889,"marketCap":15641363941},{"date":"2021-08-13","current":-10.645625,"twenty":-11.308061,"median":-6.245407,"eighty":-5.332732,"marketCap":15618225829},{"date":"2021-08-20","current":-9.220797,"twenty":-11.301942,"median":-6.419311,"eighty":-5.346099,"marketCap":13489519494},{"date":"2021-08-27","current":-9.587165,"twenty":-11.298605,"median":-7.899583,"eighty":-5.349709,"marketCap":15271154144},{"date":"2021-09-03","current":-10.209714,"twenty":-11.257766,"median":-8.052957,"eighty":-5.355236,"marketCap":16269404808},{"date":"2021-09-10","current":-9.343346,"twenty":-11.210508,"median":-8.185359,"eighty":-5.364215,"marketCap":14927121054},{"date":"2021-09-17","current":-8.949727,"twenty":-11.20047,"median":-8.434657,"eighty":-5.3787,"marketCap":14255979177},{"date":"2021-09-24","current":-8.234007,"twenty":-11.19935,"median":-8.434657,"eighty":-5.380222,"marketCap":13121980833},{"date":"2021-09-30","current":-7.839337,"twenty":-11.192661,"median":-8.399615,"eighty":-5.382695,"marketCap":12534829867},{"date":"2021-10-08","current":-7.345169,"twenty":-11.111271,"median":-8.201573,"eighty":-5.38891,"marketCap":11744135590},{"date":"2021-10-15","current":-7.158447,"twenty":-11.047167,"median":-8.13024,"eighty":-5.402482,"marketCap":11453439164},{"date":"2021-10-22","current":-7.107419,"twenty":-11.021608,"median":-8.052957,"eighty":-5.419451,"marketCap":11453439164},{"date":"2021-10-29","current":-6.9876,"twenty":-10.913219,"median":-7.905378,"eighty":-5.424788,"marketCap":11232509881},{"date":"2021-11-05","current":-6.521477,"twenty":-10.751223,"median":-7.736229,"eighty":-5.429889,"marketCap":10500496508},{"date":"2021-11-12","current":-6.911857,"twenty":-10.72568,"median":-7.556243,"eighty":-5.439163,"marketCap":11174947004},{"date":"2021-11-19","current":-7.562679,"twenty":-10.701803,"median":-7.433682,"eighty":-5.461865,"marketCap":12209879661},{"date":"2021-11-26","current":-7.617861,"twenty":-10.663803,"median":-7.561565,"eighty":-5.484543,"marketCap":12302907315},{"date":"2021-12-03","current":-7.259305,"twenty":-10.643156,"median":-7.468211,"eighty":-5.498458,"marketCap":11745511604},{"date":"2021-12-10","current":-6.694442,"twenty":-10.638167,"median":-7.415818,"eighty":-5.502206,"marketCap":10850061709},{"date":"2021-12-17","current":-6.016959,"twenty":-10.577662,"median":-7.345169,"eighty":-5.508139,"marketCap":9745285865},{"date":"2021-12-24","current":-6.061431,"twenty":-10.471572,"median":-7.288494,"eighty":-5.512987,"marketCap":9826690401},{"date":"2021-12-31","current":-5.927226,"twenty":-10.433659,"median":-7.259398,"eighty":-5.512973,"marketCap":9630021066},{"date":"2022-01-07","current":-5.24476,"twenty":-5.885319,"median":-5.561747,"eighty":-5.274171,"marketCap":8488857748},{"date":"2022-01-14","current":-5.434369,"twenty":-5.739435,"median":-5.400163,"eighty":-5.320351,"marketCap":8814904410},{"date":"2022-01-21","current":-5.350332,"twenty":-5.667482,"median":-5.495343,"eighty":-5.345425,"marketCap":8698459174},{"date":"2022-01-28","current":-4.179198,"twenty":-5.655726,"median":-5.359716,"eighty":-5.156862,"marketCap":6777112770},{"date":"2022-02-04","current":-4.314568,"twenty":-5.65234,"median":-5.352863,"eighty":-4.82542,"marketCap":6993202476},{"date":"2022-02-11","current":-4.305871,"twenty":-5.588386,"median":-5.338065,"eighty":-4.357596,"marketCap":6993202476},{"date":"2022-02-18","current":-4.549058,"twenty":-5.561747,"median":-5.217261,"eighty":-4.357596,"marketCap":7424449962},{"date":"2022-02-25","current":-4.580613,"twenty":-5.541925,"median":-4.82542,"eighty":-4.340347,"marketCap":7494381986},{"date":"2022-03-04","current":-4.265532,"twenty":-5.495343,"median":-4.615232,"eighty":-4.340347,"marketCap":6981547138},{"date":"2022-03-11","current":-3.829807,"twenty":-5.434369,"median":-4.592981,"eighty":-4.305871,"marketCap":6258916216},{"date":"2022-03-18","current":-3.70909,"twenty":-5.365958,"median":-4.554202,"eighty":-4.254145,"marketCap":6037464804},{"date":"2022-03-25","current":-4.009659,"twenty":-5.353473,"median":-4.514341,"eighty":-4.051774,"marketCap":6526988977},{"date":"2022-04-01","current":-3.604513,"twenty":-5.352254,"median":-4.446056,"eighty":-3.939197,"marketCap":5874464342},{"date":"2022-04-08","current":-3.602952,"twenty":-5.350716,"median":-4.358449,"eighty":-3.856607,"marketCap":5874464342},{"date":"2022-04-14","current":-3.608921,"twenty":-5.342972,"median":-4.33861,"eighty":-3.719598,"marketCap":5874464342},{"date":"2022-04-22","current":-3.677661,"twenty":-5.320351,"median":-4.323136,"eighty":-3.639031,"marketCap":5874464342},{"date":"2022-04-29","current":-3.73782,"twenty":-5.274171,"median":-4.305768,"eighty":-3.660706,"marketCap":5874464342},{"date":"2022-05-06","current":-3.769129,"twenty":-5.23376,"median":-4.265532,"eighty":-3.683855,"marketCap":5874464342},{"date":"2022-05-13","current":-3.837797,"twenty":-5.189762,"median":-4.179198,"eighty":-3.708631,"marketCap":5874464342},{"date":"2022-05-20","current":-3.784694,"twenty":-5.107513,"median":-4.086461,"eighty":-3.70909,"marketCap":5874464342},{"date":"2022-05-27","current":-3.78798,"twenty":-4.82542,"median":-4.009659,"eighty":-3.709727,"marketCap":5874464342},{"date":"2022-06-02","current":-3.812613,"twenty":-4.725127,"median":-3.992083,"eighty":-3.710569,"marketCap":5944398442},{"date":"2022-06-10","current":-2.879454,"twenty":-4.638595,"median":-3.924041,"eighty":-3.708998,"marketCap":6468904187},{"date":"2022-06-17","current":-2.534624,"twenty":-4.610433,"median":-3.837797,"eighty":-3.629407,"marketCap":5687973411},{"date":"2022-06-24","current":-2.91257,"twenty":-4.600342,"median":-3.834186,"eighty":-3.605183,"marketCap":6562149652},{"date":"2022-06-30","current":-2.7397,"twenty":-4.595236,"median":-3.824248,"eighty":-3.603889,"marketCap":6162036300},{"date":"2022-07-08","current":-2.789013,"twenty":-4.58556,"median":-3.810066,"eighty":-3.585543,"marketCap":6279408420},{"date":"2022-07-15","current":-2.657247,"twenty":-4.567853,"median":-3.804578,"eighty":-3.040197,"marketCap":5927292060},{"date":"2022-07-22","current":-2.439909,"twenty":-4.553174,"median":-3.796104,"eighty":-2.88352,"marketCap":5446066368},{"date":"2022-07-29","current":-2.179587,"twenty":-4.54278,"median":-3.786337,"eighty":-2.825625,"marketCap":4870942980},{"date":"2022-08-05","current":-2.179915,"twenty":-4.524043,"median":-3.773711,"eighty":-2.777759,"marketCap":4859266866},{"date":"2022-08-12","current":-2.113849,"twenty":-4.48743,"median":-3.764949,"eighty":-2.726876,"marketCap":4718418551},{"date":"2022-08-19","current":-2.12991,"twenty":-4.458004,"median":-3.759652,"eighty":-2.661134,"marketCap":4706681191},{"date":"2022-08-26","current":-2.634132,"twenty":-4.445198,"median":-3.737568,"eighty":-2.601682,"marketCap":5774780913},{"date":"2022-09-02","current":-2.482455,"twenty":-4.392287,"median":-3.726604,"eighty":-2.570557,"marketCap":5422721701},{"date":"2022-09-09","current":-2.357096,"twenty":-4.358278,"median":-3.709409,"eighty":-2.530744,"marketCap":5129284379},{"date":"2022-09-16","current":-2.422633,"twenty":-4.350696,"median":-3.693146,"eighty":-2.492961,"marketCap":5223184322},{"date":"2022-09-23","current":-2.643578,"twenty":-4.338957,"median":-3.632117,"eighty":-2.424059,"marketCap":4389822329},{"date":"2022-09-30","current":-2.491968,"twenty":-4.334804,"median":-3.607643,"eighty":-2.431682,"marketCap":4145970216},{"date":"2022-10-07","current":-2.435149,"twenty":-4.328276,"median":-3.604942,"eighty":-2.427988,"marketCap":4051205182},{"date":"2022-10-14","current":-2.569205,"twenty":-4.312829,"median":-3.604513,"eighty":-2.427988,"marketCap":4228889620},{"date":"2022-10-21","current":-2.789816,"twenty":-4.30585,"median":-3.6011,"eighty":-2.436101,"marketCap":4560567238},{"date":"2022-10-28","current":-2.620394,"twenty":-4.30145,"median":-3.574811,"eighty":-2.447476,"marketCap":4276272137},{"date":"2022-11-04","current":-2.801766,"twenty":-4.280449,"median":-3.186067,"eighty":-2.475622,"marketCap":4616748608},{"date":"2022-11-11","current":-2.534296,"twenty":-4.263255,"median":-2.894354,"eighty":-2.478687,"marketCap":4213228164},{"date":"2022-11-18","current":-2.700603,"twenty":-4.239156,"median":-2.889868,"eighty":-2.483082,"marketCap":4474329627},{"date":"2022-11-25","current":-2.418931,"twenty":-4.177717,"median":-2.865074,"eighty":-2.475622,"marketCap":3975863197},{"date":"2022-12-02","current":-2.643918,"twenty":-4.161664,"median":-2.86319,"eighty":-2.462906,"marketCap":4420662516},{"date":"2022-12-09","current":-3.149151,"twenty":-4.107273,"median":-2.864198,"eighty":-2.475622,"marketCap":5314327445},{"date":"2022-12-16","current":-3.305139,"twenty":-4.051044,"median":-2.882842,"eighty":-2.478576,"marketCap":5564553626},{"date":"2022-12-23","current":-3.381937,"twenty":-4.04043,"median":-2.894354,"eighty":-2.482013,"marketCap":5695624482},{"date":"2022-12-30","current":-3.236489,"twenty":-4.017352,"median":-2.91136,"eighty":-2.482344,"marketCap":5516891496},{"date":"2023-01-06","current":-3.391948,"twenty":-4.007837,"median":-2.931792,"eighty":-2.484335,"marketCap":5841286276},{"date":"2023-01-13","current":-3.599992,"twenty":-3.997899,"median":-3.028307,"eighty":-2.489094,"marketCap":6318125972},{"date":"2023-01-20","current":-3.274887,"twenty":-3.960351,"median":-3.067138,"eighty":-2.491753,"marketCap":5698234367},{"date":"2023-01-27","current":-3.233118,"twenty":-3.939197,"median":-3.097872,"eighty":-2.491968,"marketCap":5626708412},{"date":"2023-02-03","current":-3.69441,"twenty":-3.928643,"median":-3.149151,"eighty":-2.494486,"marketCap":6462803880},{"date":"2023-02-10","current":-2.982995,"twenty":-3.919438,"median":-3.165799,"eighty":-2.508719,"marketCap":5186936694},{"date":"2023-02-17","current":-2.929036,"twenty":-3.863307,"median":-3.125282,"eighty":-2.512289,"marketCap":5044936998},{"date":"2023-02-24","current":-2.815147,"twenty":-3.837797,"median":-3.067138,"eighty":-2.524925,"marketCap":4789497150},{"date":"2023-03-03","current":-3.177519,"twenty":-3.836172,"median":-3.062189,"eighty":-2.525861,"marketCap":5440868762},{"date":"2023-03-10","current":-2.780338,"twenty":-2.887457,"median":-2.862997,"eighty":-2.813402,"marketCap":4725637188},{"date":"2023-03-17","current":-2.887659,"twenty":-6.745058,"median":-4.593114,"eighty":-3.296279,"marketCap":4955533051},{"date":"2023-03-24","current":-2.612069,"twenty":-6.736768,"median":-4.588347,"eighty":-3.266896,"marketCap":4534057302},{"date":"2023-03-31","current":-2.632175,"twenty":-6.734568,"median":-4.584133,"eighty":-3.247746,"marketCap":4534057302},{"date":"2023-04-06","current":-2.745164,"twenty":-6.732299,"median":-4.58201,"eighty":-3.245554,"marketCap":4725637188},{"date":"2023-04-14","current":-2.905521,"twenty":-6.72346,"median":-4.55657,"eighty":-3.235845,"marketCap":5006621020},{"date":"2023-04-21","current":-2.588135,"twenty":-6.708866,"median":-4.546798,"eighty":-3.196989,"marketCap":4457425347},{"date":"2023-04-28","current":-4.143444,"twenty":-6.693682,"median":-4.538595,"eighty":-3.180289,"marketCap":4240301476},{"date":"2023-05-05","current":-3.999602,"twenty":-6.69064,"median":-4.52917,"eighty":-3.191368,"marketCap":4099809560},{"date":"2023-05-12","current":-3.806764,"twenty":-6.679014,"median":-4.522481,"eighty":-3.196275,"marketCap":3875269876},{"date":"2023-05-19","current":-3.771563,"twenty":-6.673396,"median":-4.514341,"eighty":-3.199843,"marketCap":3785445740},{"date":"2023-05-25","current":-3.684445,"twenty":-6.661445,"median":-4.512446,"eighty":-3.226463,"marketCap":3682789585},{"date":"2023-06-02","current":-3.632573,"twenty":-6.658053,"median":-4.486619,"eighty":-3.234956,"marketCap":3618629487},{"date":"2023-06-09","current":-3.392773,"twenty":-6.652326,"median":-4.462291,"eighty":-3.236274,"marketCap":3374873717},{"date":"2023-06-16","current":-3.564649,"twenty":-6.635685,"median":-4.45465,"eighty":-3.234956,"marketCap":3528860351},{"date":"2023-06-23","current":-3.010726,"twenty":-6.610775,"median":-4.450713,"eighty":-3.234497,"marketCap":2964242695},{"date":"2023-06-30","current":-3.274952,"twenty":-6.583541,"median":-4.44228,"eighty":-3.234497,"marketCap":3195222645},{"date":"2023-07-07","current":-3.189107,"twenty":-6.573211,"median":-4.4415,"eighty":-3.21706,"marketCap":3105397109},{"date":"2023-07-14","current":-3.365903,"twenty":-6.569768,"median":-4.430064,"eighty":-3.234037,"marketCap":3323544840},{"date":"2023-07-21","current":-3.120491,"twenty":-6.567361,"median":-4.417451,"eighty":-3.210165,"marketCap":3066900450},{"date":"2023-07-28","current":-3.346032,"twenty":-6.564413,"median":-4.408129,"eighty":-3.196989,"marketCap":3285048181},{"date":"2023-08-04","current":-3.027308,"twenty":-6.564342,"median":-4.399316,"eighty":-3.194165,"marketCap":2977074914},{"date":"2023-08-11","current":-2.782359,"twenty":-6.564014,"median":-4.396571,"eighty":-3.189107,"marketCap":2720740259},{"date":"2023-08-18","current":-3.530437,"twenty":-6.55969,"median":-4.392518,"eighty":-3.172846,"marketCap":2849077064},{"date":"2023-08-25","current":-3.655856,"twenty":-6.554405,"median":-4.381873,"eighty":-3.176536,"marketCap":2951746508},{"date":"2023-09-01","current":-3.530032,"twenty":-6.533968,"median":-4.371418,"eighty":-3.184472,"marketCap":2861990034},{"date":"2023-09-08","current":-3.411902,"twenty":-6.518159,"median":-4.359552,"eighty":-3.189107,"marketCap":2733649674},{"date":"2023-09-15","current":-3.09954,"twenty":-6.509248,"median":-4.356975,"eighty":-3.184472,"marketCap":2502637025},{"date":"2023-09-22","current":-3.081221,"twenty":-6.493183,"median":-4.345154,"eighty":-3.172846,"marketCap":2476968953},{"date":"2023-09-29","current":-2.926752,"twenty":-6.480354,"median":-4.336586,"eighty":-3.159724,"marketCap":2356828062},{"date":"2023-10-06","current":-2.754135,"twenty":-6.470259,"median":-4.332194,"eighty":-3.149993,"marketCap":2216761940},{"date":"2023-10-13","current":-3.075296,"twenty":-6.459774,"median":-4.326035,"eighty":-3.128987,"marketCap":2471562163},{"date":"2023-10-20","current":-2.889523,"twenty":-6.458144,"median":-4.318868,"eighty":-3.124306,"marketCap":2318682029},{"date":"2023-10-27","current":-3.129013,"twenty":-6.456543,"median":-4.317435,"eighty":-3.120688,"marketCap":2509782196},{"date":"2023-11-03","current":-3.405912,"twenty":-6.449456,"median":-4.315677,"eighty":-3.121913,"marketCap":2739136797},{"date":"2023-11-10","current":-3.707675,"twenty":-6.422586,"median":-4.311136,"eighty":-3.12398,"marketCap":2981200049},{"date":"2023-11-17","current":-3.643128,"twenty":-6.418119,"median":-4.306778,"eighty":-3.125305,"marketCap":2955719706},{"date":"2023-11-24","current":-3.862579,"twenty":-6.411963,"median":-4.304547,"eighty":-3.125437,"marketCap":3159562445},{"date":"2023-12-01","current":-3.443396,"twenty":-6.402415,"median":-4.299316,"eighty":-3.125763,"marketCap":2828353515},{"date":"2023-12-08","current":-3.70655,"twenty":-6.380708,"median":-4.294096,"eighty":-3.126978,"marketCap":3032198813},{"date":"2023-12-15","current":-3.933018,"twenty":-6.355629,"median":-4.286687,"eighty":-3.129763,"marketCap":3236044112},{"date":"2023-12-22","current":-3.362344,"twenty":-6.341861,"median":-4.283518,"eighty":-3.135873,"marketCap":2764651859},{"date":"2023-12-29","current":-3.498637,"twenty":-6.326391,"median":-4.279732,"eighty":-3.145199,"marketCap":2892055171},{"date":"2024-01-05","current":-3.352806,"twenty":-6.311476,"median":-4.275394,"eighty":-3.148813,"marketCap":2751961912},{"date":"2024-01-12","current":-3.319994,"twenty":-6.301095,"median":-4.271829,"eighty":-3.150414,"marketCap":2726480783},{"date":"2024-01-19","current":-2.920642,"twenty":-6.289048,"median":-4.265098,"eighty":-3.14209,"marketCap":2395226109},{"date":"2024-01-26","current":-2.776093,"twenty":-6.275971,"median":-4.258402,"eighty":-3.125512,"marketCap":2267820464},{"date":"2024-02-02","current":-2.436086,"twenty":-6.260618,"median":-4.252597,"eighty":-3.121083,"marketCap":1987528047},{"date":"2024-02-09","current":-2.501845,"twenty":-6.25276,"median":-4.24782,"eighty":-3.105335,"marketCap":2051230870},{"date":"2024-02-16","current":-2.392552,"twenty":-6.251579,"median":-4.245111,"eighty":-3.084885,"marketCap":1962046919},{"date":"2024-02-23","current":-2.51456,"twenty":-6.247289,"median":-4.239252,"eighty":-3.064189,"marketCap":2051230870},{"date":"2024-03-01","current":-2.310081,"twenty":-6.222174,"median":-4.222385,"eighty":-3.040692,"marketCap":1885603532},{"date":"2024-03-08","current":-1.404154,"twenty":-6.191591,"median":-4.219168,"eighty":-3.008293,"marketCap":1146650796},{"date":"2024-03-15","current":-1.639631,"twenty":-6.153575,"median":-4.207661,"eighty":-2.990736,"marketCap":1337759263},{"date":"2024-03-22","current":-1.469204,"twenty":-6.137344,"median":-4.193365,"eighty":-2.948454,"marketCap":1197613054},{"date":"2024-03-28","current":-1.473918,"twenty":-6.118661,"median":-4.179198,"eighty":-2.936832,"marketCap":1197613054},{"date":"2024-04-05","current":-1.380747,"twenty":-6.07926,"median":-4.170971,"eighty":-2.929036,"marketCap":1121169668},{"date":"2024-04-12","current":-1.34863,"twenty":-6.060479,"median":-4.143701,"eighty":-2.916836,"marketCap":1095711942},{"date":"2024-04-19","current":-1.334087,"twenty":-6.029373,"median":-4.129341,"eighty":-2.905689,"marketCap":1082971105},{"date":"2024-04-26","current":-2.889721,"twenty":-6.019873,"median":-4.121148,"eighty":-2.897368,"marketCap":1146675288},{"date":"2024-05-03","current":-3.534325,"twenty":-5.992843,"median":-4.105499,"eighty":-2.894248,"marketCap":1401492019},{"date":"2024-05-10","current":-3.465269,"twenty":-5.966361,"median":-4.068484,"eighty":-2.894248,"marketCap":1377371440},{"date":"2024-05-17","current":-4.209422,"twenty":-5.951813,"median":-4.055358,"eighty":-2.894248,"marketCap":1670700543},{"date":"2024-05-24","current":-4.186851,"twenty":-5.939876,"median":-4.055358,"eighty":-2.894248,"marketCap":1657947103},{"date":"2024-05-31","current":-3.732161,"twenty":-5.929989,"median":-4.038887,"eighty":-2.894248,"marketCap":1479398954},{"date":"2024-06-07","current":-3.76901,"twenty":-5.876484,"median":-4.028312,"eighty":-2.894248,"marketCap":1492152393},{"date":"2024-06-14","current":-3.482276,"twenty":-5.858022,"median":-3.999602,"eighty":-2.894248,"marketCap":1377371440},{"date":"2024-06-21","current":-3.521893,"twenty":-5.826591,"median":-3.984491,"eighty":-2.894248,"marketCap":1390124879},{"date":"2024-06-28","current":-3.684975,"twenty":-5.785726,"median":-3.960681,"eighty":-2.894248,"marketCap":1453892075},{"date":"2024-07-05","current":-3.976759,"twenty":-5.708926,"median":-3.94724,"eighty":-2.894248,"marketCap":1568673028},{"date":"2024-07-12","current":-3.809506,"twenty":-5.666111,"median":-3.939197,"eighty":-2.894248,"marketCap":1504905832},{"date":"2024-07-19","current":-3.938567,"twenty":-5.64627,"median":-3.936259,"eighty":-2.894248,"marketCap":1555919589},{"date":"2024-07-26","current":-3.859662,"twenty":-5.597338,"median":-3.926532,"eighty":-2.894248,"marketCap":1530412711},{"date":"2024-08-02","current":-4.119373,"twenty":-5.565391,"median":-3.926532,"eighty":-2.894248,"marketCap":1632440225},{"date":"2024-08-09","current":-3.996192,"twenty":-5.542318,"median":-3.926532,"eighty":-2.894248,"marketCap":1594179907},{"date":"2024-08-16","current":-4.218339,"twenty":-5.531989,"median":-3.926532,"eighty":-2.894248,"marketCap":1683453982},{"date":"2024-08-23","current":-4.073295,"twenty":-5.531989,"median":-3.926532,"eighty":-2.894248,"marketCap":1632440225},{"date":"2024-08-30","current":-4.899612,"twenty":-5.531989,"median":-3.926532,"eighty":-2.894248,"marketCap":1976783085},{"date":"2024-09-06","current":-4.739277,"twenty":-5.531989,"median":-3.926532,"eighty":-2.894248,"marketCap":1913015889},{"date":"2024-09-13","current":-4.720038,"twenty":-5.531989,"median":-3.926532,"eighty":-2.894248,"marketCap":1900262449},{"date":"2024-09-20","current":-4.628923,"twenty":-5.53413,"median":-3.925687,"eighty":-2.894194,"marketCap":1874755571},{"date":"2024-09-27","current":-5.446446,"twenty":-5.53413,"median":-3.925687,"eighty":-2.894194,"marketCap":2219126271},{"date":"2024-10-04","current":-15.755499,"twenty":-5.548662,"median":-3.925687,"eighty":-2.894194,"marketCap":2476357202},{"date":"2024-10-10","current":-14.135917,"twenty":-5.573446,"median":-3.926532,"eighty":-2.894248,"marketCap":2208297918},{"date":"2024-10-18","current":-14.462213,"twenty":-5.610768,"median":-3.925687,"eighty":-2.894194,"marketCap":2246592101},{"date":"2024-10-25","current":-17.175371,"twenty":-5.653982,"median":-3.925687,"eighty":-2.894194,"marketCap":2667890820},{"date":"2024-11-01","current":-17.245924,"twenty":-5.680834,"median":-3.925687,"eighty":-2.894194,"marketCap":2680655848},{"date":"2024-11-08","current":-16.219086,"twenty":-5.78614,"median":-3.925687,"eighty":-2.894194,"marketCap":2501945458},{"date":"2024-11-15","current":-15.508794,"twenty":-5.827373,"median":-3.925687,"eighty":-2.894194,"marketCap":2374295180},{"date":"2024-11-22","current":-16.352011,"twenty":-5.9148,"median":-3.925687,"eighty":-2.894194,"marketCap":2501945458},{"date":"2024-11-29","current":-17.863888,"twenty":-5.953064,"median":-3.925687,"eighty":-2.894194,"marketCap":2731715959},{"date":"2024-12-06","current":-18.910143,"twenty":-5.976081,"median":-3.925687,"eighty":-2.894194,"marketCap":2884896294},{"date":"2024-12-13","current":-22.026126,"twenty":-6.008757,"median":-3.925687,"eighty":-2.894194,"marketCap":3357202324},{"date":"2024-12-20","current":-19.368719,"twenty":-6.038268,"median":-3.925687,"eighty":-2.894194,"marketCap":2935956405},{"date":"2024-12-27","current":-19.29948,"twenty":-6.089632,"median":-3.925687,"eighty":-2.894194,"marketCap":2923191377},{"date":"2025-01-03","current":-20.796109,"twenty":-6.174931,"median":-3.925687,"eighty":-2.894194,"marketCap":3152961878},{"date":"2025-01-10","current":-18.25524,"twenty":-6.25082,"median":-3.925687,"eighty":-2.894194,"marketCap":2757246015},{"date":"2025-01-17","current":-18.24052,"twenty":-6.445489,"median":-3.927588,"eighty":-2.894194,"marketCap":2757246015},{"date":"2025-01-24","current":-20.141042,"twenty":-6.555254,"median":-3.927588,"eighty":-2.894194,"marketCap":3063606684},{"date":"2025-01-28","current":-19.53514,"twenty":-6.564014,"median":-3.928643,"eighty":-2.894248,"marketCap":2987016516},{"date":"2025-02-07","current":-19.814213,"twenty":-6.620453,"median":-3.926532,"eighty":-2.894141,"marketCap":3012546572},{"date":"2025-02-14","current":-22.723068,"twenty":-6.67789,"median":-3.926532,"eighty":-2.894141,"marketCap":3446557519},{"date":"2025-02-21","current":-26.033767,"twenty":-6.7434,"median":-3.926532,"eighty":-2.894141,"marketCap":3970369498},{"date":"2025-02-28","current":-28.807424,"twenty":-6.911713,"median":-3.926532,"eighty":-2.894141,"marketCap":4378896263},{"date":"2025-03-07","current":-28.524923,"twenty":-6.9876,"median":-3.922985,"eighty":-2.894088,"marketCap":4353363340},{"date":"2025-03-14","current":-30.855919,"twenty":-7.094956,"median":-3.927588,"eighty":-2.894088,"marketCap":4710824260},{"date":"2025-03-21","current":-29.696894,"twenty":-7.19083,"median":-3.938173,"eighty":-2.894088,"marketCap":4532093800},{"date":"2025-03-28","current":-44.206211,"twenty":-7.281486,"median":-3.953184,"eighty":-2.894088,"marketCap":4315063956},{"date":"2025-04-03","current":-40.26858,"twenty":-7.377266,"median":-3.972131,"eighty":-2.894088,"marketCap":3932070114},{"date":"2025-04-11","current":-31.529554,"twenty":-7.521044,"median":-3.977907,"eighty":-2.894088,"marketCap":3051184276},{"date":"2025-04-17","current":-35.141039,"twenty":-7.612577,"median":-3.984806,"eighty":-2.894141,"marketCap":3405181813},{"date":"2025-04-25","current":-39.824039,"twenty":-7.830066,"median":-3.999602,"eighty":-2.893971,"marketCap":3866441501},{"date":"2025-05-02","current":-40.436758,"twenty":-7.971418,"median":-4.00659,"eighty":-2.894088,"marketCap":3934273808},{"date":"2025-05-09","current":-37.951173,"twenty":-8.125706,"median":-4.030136,"eighty":-2.904367,"marketCap":3718361371},{"date":"2025-05-16","current":-39.292255,"twenty":-8.402557,"median":-4.054969,"eighty":-2.909393,"marketCap":3881209314},{"date":"2025-05-23","current":-48.489427,"twenty":-8.76248,"median":-4.07123,"eighty":-2.912068,"marketCap":4804014326},{"date":"2025-05-30","current":-54.004979,"twenty":-8.882707,"median":-4.108578,"eighty":-2.920581,"marketCap":5373982128},{"date":"2025-06-06","current":-53.187404,"twenty":-9.067711,"median":-4.134025,"eighty":-2.920581,"marketCap":5306128818},{"date":"2025-06-13","current":-62.277497,"twenty":-9.366509,"median":-4.171793,"eighty":-2.920581,"marketCap":6215439503},{"date":"2025-06-20","current":-55.860088,"twenty":-9.719391,"median":-4.1939,"eighty":-2.920581,"marketCap":5564039730},{"date":"2025-06-27","current":-57.470323,"twenty":-9.919518,"median":-4.210698,"eighty":-2.920642,"marketCap":5740460502},{"date":"2025-07-04","current":-70.509918,"twenty":-9.96315,"median":-4.214054,"eighty":-2.920642,"marketCap":7043260048},{"date":"2025-07-11","current":-72.89851,"twenty":-10.187483,"median":-4.217237,"eighty":-2.920642,"marketCap":7274522110},{"date":"2025-07-18","current":-96.028249,"twenty":-10.444237,"median":-4.259839,"eighty":-2.920642,"marketCap":9575122927},{"date":"2025-07-25","current":-109.369715,"twenty":-10.675922,"median":-4.302518,"eighty":-2.920642,"marketCap":10945079632},{"date":"2025-08-01","current":-98.766317,"twenty":-11.028128,"median":-4.334288,"eighty":-2.920642,"marketCap":9822881055},{"date":"2025-08-08","current":-102.320343,"twenty":-11.210508,"median":-4.343155,"eighty":-2.920642,"marketCap":10201805250},{"date":"2025-08-15","current":-136.537801,"twenty":-11.629311,"median":-4.351854,"eighty":-2.920642,"marketCap":13593043587},{"date":"2025-08-22","current":-34.413615,"twenty":-11.870503,"median":-4.358449,"eighty":-2.920642,"marketCap":14120359933},{"date":"2025-08-29","current":-38.22937,"twenty":-12.785549,"median":-4.358449,"eighty":-2.920642,"marketCap":15760899677},{"date":"2025-09-05","current":-43.631932,"twenty":-13.262082,"median":-4.358449,"eighty":-2.920642,"marketCap":17970398621},{"date":"2025-09-12","current":-35.323219,"twenty":-13.467457,"median":-4.378646,"eighty":-2.920642,"marketCap":14574532540},{"date":"2025-09-19","current":-30.095318,"twenty":-13.678999,"median":-4.405143,"eighty":-2.920642,"marketCap":12408662899},{"date":"2025-09-26","current":-26.446279,"twenty":-14.059898,"median":-4.4171,"eighty":-2.920642,"marketCap":10875828070},{"date":"2025-10-03","current":-28.012348,"twenty":-14.148515,"median":-4.421903,"eighty":-2.921048,"marketCap":11547355709},{"date":"2025-10-10","current":-24.116553,"twenty":-14.462213,"median":-4.4171,"eighty":-2.920642,"marketCap":9926930319},{"date":"2025-10-17","current":-24.725072,"twenty":-15.180426,"median":-4.4171,"eighty":-2.920642,"marketCap":10169487889},{"date":"2025-10-24","current":-22.615857,"twenty":-15.755499,"median":-4.4171,"eighty":-2.920642,"marketCap":9305344739},{"date":"2025-10-31","current":-22.367787,"twenty":-16.219086,"median":-4.4171,"eighty":-2.920642,"marketCap":9217002859},{"date":"2025-11-07","current":-19.414218,"twenty":-16.550087,"median":-4.4171,"eighty":-2.920642,"marketCap":7994940179},{"date":"2025-11-14","current":-21.676779,"twenty":-16.716727,"median":-4.4171,"eighty":-2.920642,"marketCap":8951977217},{"date":"2025-11-21","current":-19.867752,"twenty":-17.175371,"median":-4.4171,"eighty":-2.920642,"marketCap":8201071234},{"date":"2025-11-28","current":-21.715013,"twenty":-17.817357,"median":-4.4171,"eighty":-2.920642,"marketCap":8996148158},{"date":"2025-12-05","current":-20.116662,"twenty":-18.156074,"median":-4.4171,"eighty":-2.920642,"marketCap":8348307701},{"date":"2025-12-12","current":-21.673135,"twenty":-18.597879,"median":-4.4171,"eighty":-2.920642,"marketCap":9010871804},{"date":"2025-12-19","current":-21.268873,"twenty":-18.932983,"median":-4.4171,"eighty":-2.920642,"marketCap":8863635337},{"date":"2025-12-24","current":-19.934886,"twenty":-19.027132,"median":-4.4171,"eighty":-2.920642,"marketCap":8333584054},{"date":"2026-01-02","current":-18.734094,"twenty":-19.229249,"median":-4.412297,"eighty":-2.920581,"marketCap":7862427359},{"date":"2026-01-09","current":-20.262357,"twenty":-19.347505,"median":-4.412297,"eighty":-2.920581,"marketCap":8524991462},{"date":"2026-01-16","current":-21.312952,"twenty":-19.438402,"median":-4.412297,"eighty":-2.920581,"marketCap":8996148158},{"date":"2026-01-23","current":-19.727354,"twenty":-19.550014,"median":-4.412297,"eighty":-2.920581,"marketCap":8318882544},{"date":"2026-01-30","current":-18.664391,"twenty":-19.550014,"median":-4.412297,"eighty":-2.920581,"marketCap":7906619339},{"date":"2026-02-06","current":-17.611774,"twenty":-19.550014,"median":-4.412297,"eighty":-2.920581,"marketCap":7479632447},{"date":"2026-02-13","current":-20.40709,"twenty":-19.573276,"median":-4.4171,"eighty":-2.920642,"marketCap":8716570064},{"date":"2026-02-20","current":-21.334077,"twenty":-19.730666,"median":-4.385799,"eighty":-2.920519,"marketCap":9099392398},{"date":"2026-02-27","current":-22.809976,"twenty":-19.827105,"median":-4.385799,"eighty":-2.920519,"marketCap":9835589194},{"date":"2026-03-06","current":-22.892085,"twenty":-19.876517,"median":-4.385799,"eighty":-2.920519,"marketCap":9791417386},{"date":"2026-03-13","current":-24.363526,"twenty":-19.939651,"median":-4.385799,"eighty":-2.920519,"marketCap":10468779101},{"date":"2026-03-20","current":-23.561814,"twenty":-20.090468,"median":-4.385799,"eighty":-2.920519,"marketCap":10085954549},{"date":"2026-03-27","current":-24.787283,"twenty":-20.254301,"median":-4.385799,"eighty":-2.920519,"marketCap":12265109692},{"date":"2026-03-30","current":-26.007154,"twenty":-20.271147,"median":-4.385799,"eighty":-2.920519,"marketCap":12883518585}],"updateTime":1774955452365},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02616\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2620540981","title":"CStone Pharmaceuticals to present preclinical data for three pipeline assets at AACR Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2620540981","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620540981?lang=en_us&edition=fundamental","pubTime":"2026-03-18 06:29","pubTimestamp":1773786580,"startTime":"0","endTime":"0","summary":"CStone will attend the 2026 American Association for Cancer Research  Annual Meeting on April 17-22, 2026, at the San Diego Convention Center in California. The company said it will present three preclinical poster presentations on April 20, 2026, from 9:00 AM to 12:00 PM PT.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CStone Pharmaceuticals published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on March 17, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260317:nNDLc8LQY9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1161","02616"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618247642","title":"CStone Pharmaceuticals (SEHK:2616) Valuation Check After New UK Approval For Sugemalimab In Stage III Lung Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2618247642","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618247642?lang=en_us&edition=fundamental","pubTime":"2026-03-09 14:25","pubTimestamp":1773037547,"startTime":"0","endTime":"0","summary":"CStone Pharmaceuticals (SEHK:2616) is back on investors radar after the UK regulator granted a new indication for its cancer drug sugemalimab, extending its use in specific stage III lung cancer patients.\nSee our latest analysis for CStone Pharmaceuticals.\nThe MHRA decision lands at a time when CStone’s 1 month share price return of 30.91% and 90 day share price return of 18.75% suggest building momentum. However, the 1 year total shareholder return of 100.30% contrasts with a 5 year total...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2616/cstone-pharmaceuticals-shares/news/cstone-pharmaceuticals-sehk2616-valuation-check-after-new-uk","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2616/cstone-pharmaceuticals-shares/news/cstone-pharmaceuticals-sehk2616-valuation-check-after-new-uk","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["III","BK1574","SSI","DCF","02616","BK4134","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1135152718","title":"CSTONE PHARMA-B Shares Surge Over 9% Following FTSE China Inclusion and Progress in Triple Antibody Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=1135152718","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1135152718?lang=en_us&edition=fundamental","pubTime":"2026-03-06 11:59","pubTimestamp":1772769544,"startTime":"0","endTime":"0","summary":"CSTONE PHARMA-B (02616) rose more than 9% again. At the time of writing, the stock was up 9.18% to HK$7.02, with a turnover of HK$70.8136 million. On the news front, according to the semi-annual...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TZA","02616","BK4585","RWM","BK4535","TWM","BK4588","BK4614","BK1161","BK1574","BK4534","IWO","SRTY","UWM","IWN","MNQmain","BK4581","BK4550"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146420730","title":"CSTONE PHARMA-B Surges Over 12% on Promising Prospects for Major Business Development Deal for its Proprietary Tri-Specific Antibody","url":"https://stock-news.laohu8.com/highlight/detail?id=1146420730","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146420730?lang=en_us&edition=fundamental","pubTime":"2026-03-05 11:07","pubTimestamp":1772680057,"startTime":"0","endTime":"0","summary":"CSTONE PHARMA-B (02616) saw its shares surge more than 12%. At the time of writing, the stock was up 12.71%, trading at HK$6.65 with a turnover of HK$36.9543 million. The movement follows a previous...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK4585","BK4588","VXUS","LU1169589451.USD","PD","02616","LU1169590202.USD","BK4023","VT","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616980075","title":"CStone Pharmaceuticals (SEHK:2616) Valuation After New Sugemalimab Indication And US Phase II Trial Clearance","url":"https://stock-news.laohu8.com/highlight/detail?id=2616980075","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616980075?lang=en_us&edition=fundamental","pubTime":"2026-03-02 12:29","pubTimestamp":1772425765,"startTime":"0","endTime":"0","summary":"CStone Pharmaceuticals (SEHK:2616) has been in focus after fresh regulatory progress for its lead cancer drug sugemalimab, along with a new U.S. trial clearance that extends its immunotherapy pipeline into advanced solid tumors.\nSee our latest analysis for CStone Pharmaceuticals.\nThose approvals for sugemalimab and the U.S. FDA clearance for a new Phase II trial have arrived alongside strong momentum, with a 30 day share price return of 24.39% and a 1 year total shareholder return of 94.75%...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2616/cstone-pharmaceuticals-shares/news/cstone-pharmaceuticals-sehk2616-valuation-after-new-sugemali","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2616/cstone-pharmaceuticals-shares/news/cstone-pharmaceuticals-sehk2616-valuation-after-new-sugemali","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["02616","BK1161","BK1574","DCF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104204025","title":"CSTONE PHARMA-B Shares Surge Over 8% in Late Trading Following UK Approval for New Lung Cancer Indication","url":"https://stock-news.laohu8.com/highlight/detail?id=1104204025","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104204025?lang=en_us&edition=fundamental","pubTime":"2026-02-27 16:00","pubTimestamp":1772179230,"startTime":"0","endTime":"0","summary":"CSTONE PHARMA-B (02616) saw its shares rise more than 8% in late trading. At the time of writing, the stock was up 6.73%, trading at HK$6.66, with a turnover of HK$93.123 million. The move follows...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","III","BK4585","VXUS","02616","BK4588","VT","BK1574","BK4134"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109278324","title":"CStone Pharmaceuticals-B Sees Further Gains Exceeding 6%, Surpassing 25% Monthly Increase","url":"https://stock-news.laohu8.com/highlight/detail?id=1109278324","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109278324?lang=en_us&edition=fundamental","pubTime":"2026-02-25 14:10","pubTimestamp":1771999823,"startTime":"0","endTime":"0","summary":"CStone Pharmaceuticals-B (02616) rose more than 6% again, bringing its cumulative increase for the month to over 25%. As of the time of writing, the stock was up 5.03%, trading at HK$6.68 with a...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VT","BK4588","VXUS","BK1161","02616","BK1574","III","BK4134","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161661386","title":"CStone Pharmaceuticals-B Shares Climb Over 5% Following UK Regulatory Approval for Sugemalimab's New Lung Cancer Indication","url":"https://stock-news.laohu8.com/highlight/detail?id=1161661386","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1161661386?lang=en_us&edition=fundamental","pubTime":"2026-02-24 10:36","pubTimestamp":1771900611,"startTime":"0","endTime":"0","summary":"CStone Pharmaceuticals-B (02616) rose more than 5% in Hong Kong trading. At the time of writing, the stock was up 5.12% to HK$6.36, with a turnover of HK$23.93 million. The increase follows the...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","III","BK4134","VT","BK1574","VXUS","02616","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160494555","title":"CStone (HKEX: 2616) Gains UK MHRA Approval for Sugemalimab in Stage III NSCLC","url":"https://stock-news.laohu8.com/highlight/detail?id=1160494555","media":"Bulletin Express","labels":["corporation","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160494555?lang=en_us&edition=fundamental","pubTime":"2026-02-23 08:23","pubTimestamp":1771806232,"startTime":"0","endTime":"0","summary":"CStone (HKEX: 2616) announced that the United Kingdom Medicines and Healthcare products Regulatory Agency (MHRA) approved a new indication for the anti-PD-L1 monoclonal antibody sugemalimab. The...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02616"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167405741","title":"CStone Pharma-B's PD-L1 Antibody Sugemalimab Gains UK Approval for Advanced Lung Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=1167405741","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167405741?lang=en_us&edition=fundamental","pubTime":"2026-02-23 08:20","pubTimestamp":1771806029,"startTime":"0","endTime":"0","summary":"CStone Pharmaceuticals-B (02616) announced that its new indication application for sugemalimab has been approved by the UK Medicines and Healthcare products Regulatory Agency (MHRA). The approval...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["III","02616","BK4134","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613727222","title":"CStone Pharmaceuticals -  Sugemalimab Receives UK Mhra Approval for Stage Iii Nsclc","url":"https://stock-news.laohu8.com/highlight/detail?id=2613727222","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613727222?lang=en_us&edition=fundamental","pubTime":"2026-02-23 08:07","pubTimestamp":1771805234,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260223:nFWN3ZI00J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1574","BK1161","02616"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613272275","title":"UK MHRA approves CStone’s sugemalimab for unresectable stage III NSCLC","url":"https://stock-news.laohu8.com/highlight/detail?id=2613272275","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613272275?lang=en_us&edition=fundamental","pubTime":"2026-02-23 08:06","pubTimestamp":1771805215,"startTime":"0","endTime":"0","summary":"CStone Pharmaceuticals said the UK Medicines and Healthcare products Regulatory Agency  has approved a new indication for sugemalimab as monotherapy for adult patients with unresectable stage III non-small cell lung cancer  with PD-L1 expression on at least 1% of tumor cells, without sensitising EGFR mutations or ALK/ROS1 genomic aberrations, whose disease has not progressed after platinum-based chemoradiotherapy. The company said the approval was based on results from the Phase III GEMSTONE-301 trial.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CStone Pharmaceuticals published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on February 23, 202","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260223:nNDL7T8KFm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02616","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111533614","title":"CSTONE PHARMA-B Receives FDA Clearance for Phase II Trial of CS2009","url":"https://stock-news.laohu8.com/highlight/detail?id=1111533614","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111533614?lang=en_us&edition=fundamental","pubTime":"2026-02-20 10:20","pubTimestamp":1771554023,"startTime":"0","endTime":"0","summary":"CSTONE PHARMA-B (02616) has announced that the Investigational New Drug (IND) application for a Phase II clinical trial of its core asset, CS2009, for the treatment of advanced solid tumors has been...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4023","BK1161","BK1574","02616","LU1169589451.USD","PD","LU1169590202.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118093270","title":"CStone Pharmaceuticals (HKEX: 2616) Announces U.S. FDA IND Clearance for Phase II Trial of CS2009 Trispecific Antibody","url":"https://stock-news.laohu8.com/highlight/detail?id=1118093270","media":"Bulletin Express","labels":["productRelease","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1118093270?lang=en_us&edition=fundamental","pubTime":"2026-02-16 08:41","pubTimestamp":1771202503,"startTime":"0","endTime":"0","summary":"CStone Pharmaceuticals (HKEX: 2616) reported that the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application for CS2009 (PD-1/VEGF/CTLA-4 trispecific...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02616"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178342087","title":"CStone Pharmaceuticals' CS2009 Tri-Specific Antibody Phase II Trial Receives FDA Clearance","url":"https://stock-news.laohu8.com/highlight/detail?id=1178342087","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178342087?lang=en_us&edition=fundamental","pubTime":"2026-02-16 08:12","pubTimestamp":1771200745,"startTime":"0","endTime":"0","summary":"CStone Pharmaceuticals-B (02616) has announced that the Investigational New Drug (IND) application for a Phase II clinical trial of its core asset CS2009, a PD-1/VEGF/CTLA-4 tri-specific antibody for...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PD","BK1574","LU1169590202.USD","BK4023","LU1169589451.USD","02616","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2611715081","title":"CStone Pharmaceuticals Receives FDA Clearance for Phase II Trial of CS2009","url":"https://stock-news.laohu8.com/highlight/detail?id=2611715081","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611715081?lang=en_us&edition=fundamental","pubTime":"2026-02-16 08:00","pubTimestamp":1771200038,"startTime":"0","endTime":"0","summary":"CStone Pharmaceuticals announced that the U.S. Food and Drug Administration  has cleared the Investigational New Drug  application for its core asset, CS2009, a PD-1/VEGF/CTLA-4 trispecific antibody. This clearance enables CStone to initiate a Phase II clinical trial of CS2009 in patients with advanced solid tumors. The company stated that this development represents a significant milestone in the global advancement of its innovative immunotherapy pipeline.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CStone Pharmaceuticals published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on February 16, 2026, and is solely responsible for the informati","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260216:nNDL7B1XbL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1574","02616"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2611715731","title":"CStone Pharmaceuticals - FDA Clears Ind Application for Cs2009 Phase Ii Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2611715731","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611715731?lang=en_us&edition=fundamental","pubTime":"2026-02-16 08:00","pubTimestamp":1771200027,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260216:nFWN3ZB05L:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02616","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175414841","title":"CStone Pharmaceuticals (2616) Updates Joint Company Secretary Qualification and Announces Personnel Changes","url":"https://stock-news.laohu8.com/highlight/detail?id=1175414841","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1175414841?lang=en_us&edition=fundamental","pubTime":"2026-02-06 18:22","pubTimestamp":1770373335,"startTime":"0","endTime":"0","summary":"CStone Pharmaceuticals (the Company) announced that the Stock Exchange of Hong Kong has confirmed the qualification of Joint Company Secretary Ms. Ni under Rule 3.28 of the Listing Rules, effective...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02616"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155847358","title":"CStone Pharmaceuticals-B Receives Exchange Approval for Company Secretary Qualification","url":"https://stock-news.laohu8.com/highlight/detail?id=1155847358","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155847358?lang=en_us&edition=fundamental","pubTime":"2026-02-06 18:20","pubTimestamp":1770373226,"startTime":"0","endTime":"0","summary":"CStone Pharmaceuticals-B (02616) has announced that The Stock Exchange of Hong Kong has confirmed that Ms. Ni Weicong, the Joint Company Secretary, meets the qualifications under Rule 3.28 of the...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02616","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609616985","title":"CStone Pharmaceuticals Appoints Weicong Ni as Sole Company Secretary","url":"https://stock-news.laohu8.com/highlight/detail?id=2609616985","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609616985?lang=en_us&edition=fundamental","pubTime":"2026-02-06 18:11","pubTimestamp":1770372683,"startTime":"0","endTime":"0","summary":"CStone Pharmaceuticals has announced that Ms. Weicong Ni will serve as the sole company secretary following the resignation of Ms. Mei Yee Yung, effective February 6, 2026. The board composition remains unchanged.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CStone Pharmaceuticals published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on February 06, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260206:nNDL8DPMdw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1574","02616"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":2,"totalSize":111,"code":"91000000","status":"200"}]}}